ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 529180 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 529180; 2) Community: the network communities that were significantly associated with the response to NSC 529180; 3) Molecule: the relationships between components within communities and NSC 529180; 4) MDR: the compounds that were significantly associated with the NSC 529180.

NSC Compound Enrichment Correlation
NSC 681637 Camptothecin Derivative 0.0102962192514439 0.3928367
NSC 699168 Null 0.0102962192514439 0.30523242
NSC 705305 Null 0.0102962192514439 0.3782884
NSC 716260 Null 0.0102962192514439 0.10125629
NSC 744331 (2R,11aS)-8- {2-[4-(2-{[(2R,11aS)-C2-di-Fluoro-7-Methoxy-5-oxo-2,3,5,11a-tetrahydro-1-H-benzo[e]-pyrrolo[1,2-a][1,4]diazepine-8-yl}propyl)piperazino]propoxy}-C2-di-fluoro-7-Methoxy-2,3,5,11a-tetrahyd 0.0102962192514439 0.21922319
NSC 757306 Pyrimethamine (USAN) 0.0102962192514439 0.37357451
NSC 180260 Quinolinium, 1-methyl-4-[2-(2,4,5-trimethoxyphenyl)ethenyl]-, iodide 0.0107933723273943 0.24004297
NSC 185049 Hydrazinecarbothioamide, 2-[[5-(1-oxopropoxy)-2-pyridinyl]methylene]- 0.0107933723273943 0.30743121
NSC 208652 2,4-Quinazolinediamine, 5-chloro-6-[[(3,4-dichlorophenyl)amino]methyl]- 0.0107933723273943 0.34821142
NSC 225112 2,4,6-Quinazolinetriamine, N(6)-[(3,4-dichlorophenyl)methyl]-N(6)-ethyl-5-methyl- 0.0107933723273943 0.39183425
Total:45  Current:9    [First] [Prev] [Next] [Last]